Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasomal ATPase-associated factor 1 (PAAF1) is a WD repeat-containing protein involved in the regulation of the 26S proteasome, specifically by inhibiting assembly and proteolytic activity through modulation of 19S regulatory complex association with the 20S core particle[1][5]. PAAF1 functions as a negative regulator, ensuring proper assembly dynamics and preventing premature proteasome activity, and plays a unique functional role during HIV-1 infection by promoting proviral transcription through recruitment of the 19S regulatory complex to the viral promoter[1][5]. Alternative splicing produces multiple isoforms; orthologs have been identified in other species. PAAF1's primary molecular function is as a proteasome assembly chaperone, not as a conventional drug target such as a receptor, enzyme, or transporter[1][2][5]. Diseases associated with PAAF1 mutation or dysfunction include Mast syndrome and Xanthinuria type I[1]. No direct gene-specific therapies or drugs are known for PAAF1 at this time.
Not applicable (no established drugs; primarily acts as a chaperone/modulator of proteasome function rather than as a direct enzymatic/druggable target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasomal ATPase-associated factor 1 (PAAF1).